PHILADELPHIA, Oct. 18 /PRNewswire-FirstCall/ -- On Thursday, October 26, 2006, GlaxoSmithKline plc will announce its third quarter financial results for the three months ended September 30, 2006. It is anticipated that the announcement will be released to the London Stock Exchange at approximately 7:00am US (ET).
Following the announcement, JP Garnier, Chief Executive Officer, David Stout, President, Pharmaceutical Operations and Julian Heslop, Chief Financial Officer, will hold a global teleconference where you will be able to listen to the presentation of the third quarter 2006 results to analysts and investors.
This teleconference will take place on: Thursday, October 26 at 10:00am ET To participate in the conference please dial one of the numbers below: US Toll-Free 1 866 434 1110 International Dial-in Number +44 (0) 1452 542 302 Please quote: GSK Q3 Results A recording of the teleconference will be available from 1:00pm ET on October 26 (until November 1) on telephone numbers: US Toll-Free 1 866 247 4222 International Dial-in Number +44 (0) 1452 550 000 Passcode: 7916446#
There will also be a live audio webcast of the results presentation with synchronized slides. It will begin at the same time as the teleconference, 10:00am ET, and can be accessed directly via the GlaxoSmithKline website: http://gsk.com. Slides will be available shortly before the teleconference on the GSK website.
An archived version of this webcast will be available from the corporate website at approximately 3:00pm ET on the same day.
GlaxoSmithKlineCONTACT: US Media inquiries: Nancy Pekarek, +1-215-751 7709, Mary AnneRhyne, +1-919-483 2839, Patty Seif, +1-215-751-7709, or Gaile Renegar,+1-215-483-2839; or US Analyst/ Investor inquiries: Frank Murdolo,+1-215-751-7002, Tom Curry, +1-215-751-5419, all of GlaxoSmithKline
Web site: http://www.gsk.com/
Company News On-Call: http://www.prnewswire.com/comp/801350.html/
